 | • レポートコード：MRC-IM31170 • 出版社/出版日：IMARC / 2023年3月 • レポート形態：英文、PDF、142ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥359,856 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥647,856 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| IMARC社の本調査レポートでは、2022年に1,312億ドルであった世界の中枢神経系（CNS）治療市場規模が、2028年までに2,146億ドルに拡大し、予測期間中にCAGR6.8%で成長すると予想しています。本書は、中枢神経系（CNS）治療の世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、疾患別（神経変性疾患、神経血管系疾患、中枢神経系外傷、メンタルヘルス、その他）分析、用途別（病院、クリニック、在宅治療、その他）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ポーターズファイブフォース分析、価格分析、競争状況などの項目を整理しています。また、本書には、AstraZeneca plc、Biogen Inc.、Eli Lilly and Company、F. Hoffmann-La Roche AG (Roche Holding)、H. Lundbeck A/S、Merck & Co. Inc.、Neurocrine Biosciences Inc.、Novartis AG、Pfizer Inc.、Sanofi S.A.、Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd.などの企業情報が含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界の中枢神経系（CNS）治療市場規模：疾患別 - 神経変性疾患の市場規模 - 神経血管系疾患の市場規模 - 中枢神経系外傷の市場規模 - メンタルヘルスの市場規模 - その他の市場規模 ・世界の中枢神経系（CNS）治療市場規模：用途別 - 病院における市場規模 - クリニックにおける市場規模 - 在宅治療における市場規模 - その他における市場規模 ・世界の中枢神経系（CNS）治療市場規模：地域別 - 北米の中枢神経系（CNS）治療市場規模 - アジアの中枢神経系（CNS）治療市場規模 - 欧州の中枢神経系（CNS）治療市場規模 - 中南米の中枢神経系（CNS）治療市場規模 - 中東・アフリカの中枢神経系（CNS）治療市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ポーターズファイブフォース分析 ・価格分析 ・競争状況 |
The global central nervous system (CNS) therapeutics market size reached US$ 131.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 214.6 Billion by 2028, exhibiting a growth rate (CAGR) of 6.8% during 2023-2028.
The central nervous system (CNS) represents a vital part of the nervous system that comprises of the brain and the spinal cord. It integrates the received information, thereafter coordinating and controlling the activities of all parts of the body. CNS therapeutics primarily include anesthetics, anticonvulsants, CNS stimulants, muscle relaxants, narcotic analgesics, sedatives, etc. They are widely adopted in the treatment procedures of Parkinson’s disease, depression, Alzheimer’s disease, epilepsy, traumatic brain, spinal cord injury, CNS cancer, etc.
Central Nervous System (CNS) Therapeutics Market Trends:
The elevating prevalence of mental illness and lifestyle-associated CNS disorders, including anxiety, depression, hypertension, etc., is primarily driving the global CNS therapeutics market. In line with this, the growing geriatric population, who are more prone to chronic neurological ailments such as Alzheimer’s disease and Parkinson’s disease, is also propelling the global market. Additionally, the emerging popularity of generic neurologic drugs across developing countries on account of their affordability is further augmenting the market for CNS therapeutics. Apart from this, continuous innovations in CNS treatment procedures, such as the development of gene therapy, neurostimulation tools, and neural transplantation techniques, are also stimulating the market growth. These approaches prolong the action of unremitting dopaminergic stimulation medicines and control disease progression. Moreover, the introduction of novel drug-delivery systems that provide ease of administration and availability of different dosage forms is further creating a positive outlook for the global CNS market. For instance, transdermal patches are gaining traction in the field of neurology to treat CNS disorders as they offer a precise amount of medicine and relief for around 24 hours. Besides this, the increasing focus of the government and non-government organizations on creating awareness regarding numerous CNS disorders and the accessibility to multiple treatment options is also catalyzing the market growth. Moreover, the launch of favorable guidelines to support faster approvals of pipeline drugs for neurodegenerative diseases and clinical trials that encourage the entry of new products is expected to drive the global central nervous system therapeutics market in the coming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global central nervous system (CNS) therapeutics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on disease and application.
Breakup by Disease:
Neurodegenerative Diseases
Alzheimer’s Disease
Parkinson’s Disease
Multiple Sclerosis
Huntington’s Disease
Amyotrophic Lateral Sclerosis
Others
Neurovascular Diseases
CNS Trauma
Mental Health
Anxiety Disorders
Epilepsy
Mood Disorders
Psychotic Disorders
Others
Infectious Diseases
CNS Cancer
Others
Breakup by Application:
Hospital
Clinic
Homecare
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AstraZeneca plc, Biogen Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG (Roche Holding), H. Lundbeck A/S, Merck & Co. Inc., Neurocrine Biosciences Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd.
Key Questions Answered in This Report
1. What was the size of the global Central Nervous System (CNS) therapeutics market in 2022?
2. What is the expected growth rate of the global Central Nervous System (CNS) therapeutics market during 2023-2028
3. What are the key factors driving the global Central Nervous System (CNS) therapeutics market?
4. What has been the impact of COVID-19 on the global Central Nervous System (CNS) therapeutics market?
5. What is the breakup of the global Central Nervous System (CNS) therapeutics market based on the disease?
6. What are the key regions in the global Central Nervous System (CNS) therapeutics market?
7. Who are the key players/companies in the global Central Nervous System (CNS) therapeutics market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Central Nervous System (CNS) Therapeutics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Disease
6.1 Neurodegenerative Diseases
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Alzheimer’s Disease
6.1.2.2 Parkinson’s Disease
6.1.2.3 Multiple Sclerosis
6.1.2.4 Huntington’s Disease
6.1.2.5 Amyotrophic Lateral Sclerosis
6.1.2.6 Others
6.1.3 Market Forecast
6.2 Neurovascular Diseases
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 CNS Trauma
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Mental Health
6.4.1 Market Trends
6.4.2 Key Segments
6.4.2.1 Anxiety Disorders
6.4.2.2 Epilepsy
6.4.2.3 Mood Disorders
6.4.2.4 Psychotic Disorders
6.4.2.5 Others
6.4.3 Market Forecast
6.5 Infectious Diseases
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 CNS Cancer
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Others
6.7.1 Market Trends
6.7.2 Market Forecast
7 Market Breakup by Application
7.1 Hospital
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Clinic
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Homecare
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 AstraZeneca plc
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Biogen Inc.
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 Eli Lilly and Company
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 F. Hoffmann-La Roche AG (Roche Holding)
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 SWOT Analysis
13.3.5 H. Lundbeck A/S
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.5.4 SWOT Analysis
13.3.6 Merck & Co. Inc.
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.6.4 SWOT Analysis
13.3.7 Neurocrine Biosciences Inc.
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.7.4 SWOT Analysis
13.3.8 Novartis AG
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
13.3.9 Pfizer Inc.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Sanofi S.A.
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis
13.3.11 Takeda Pharmaceutical Company Limited
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.11.3 Financials
13.3.11.4 SWOT Analysis
13.3.12 Teva Pharmaceutical Industries Ltd.
13.3.12.1 Company Overview
13.3.12.2 Product Portfolio
13.3.12.3 Financials
13.3.12.4 SWOT Analysis
Figure 2: Global: Central Nervous System Therapeutics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Central Nervous System Therapeutics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Central Nervous System Therapeutics Market: Breakup by Disease (in %), 2022
Figure 5: Global: Central Nervous System Therapeutics Market: Breakup by Application (in %), 2022
Figure 6: Global: Central Nervous System Therapeutics Market: Breakup by Region (in %), 2022
Figure 7: Global: Central Nervous System Therapeutics (Neurodegenerative Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 8: Global: Central Nervous System Therapeutics (Neurodegenerative Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 9: Global: Central Nervous System Therapeutics (Neurovascular Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Central Nervous System Therapeutics (Neurovascular Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Central Nervous System Therapeutics (CNS Trauma) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Central Nervous System Therapeutics (CNS Trauma) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Central Nervous System Therapeutics (Mental Health) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Central Nervous System Therapeutics (Mental Health) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Central Nervous System Therapeutics (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Central Nervous System Therapeutics (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Central Nervous System Therapeutics (CNS Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Central Nervous System Therapeutics (CNS Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Central Nervous System Therapeutics (Other Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Central Nervous System Therapeutics (Other Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Central Nervous System Therapeutics (Hospital) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Central Nervous System Therapeutics (Hospital) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Central Nervous System Therapeutics (Clinic) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Central Nervous System Therapeutics (Clinic) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Central Nervous System Therapeutics (Homecare) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Central Nervous System Therapeutics (Homecare) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Central Nervous System Therapeutics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Central Nervous System Therapeutics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: North America: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: North America: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: United States: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: United States: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Canada: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Canada: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Asia-Pacific: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Asia-Pacific: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: China: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: China: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Japan: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Japan: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: India: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: India: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: South Korea: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: South Korea: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Australia: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Australia: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Indonesia: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Indonesia: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Others: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Others: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Europe: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Europe: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Germany: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Germany: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: France: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: France: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: United Kingdom: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: United Kingdom: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Italy: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Italy: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Spain: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Spain: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Russia: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Russia: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Others: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Others: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Latin America: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Latin America: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Brazil: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Brazil: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Mexico: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Mexico: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Others: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Others: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Middle East and Africa: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Middle East and Africa: Central Nervous System Therapeutics Market: Breakup by Country (in %), 2022
Figure 77: Middle East and Africa: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Global: Central Nervous System Therapeutics Industry: SWOT Analysis
Figure 79: Global: Central Nervous System Therapeutics Industry: Value Chain Analysis
Figure 80: Global: Central Nervous System Therapeutics Industry: Porter's Five Forces Analysis
• 日本語訳：中枢神経系（CNS）治療の世界市場：動向・シェア・規模・予測
• レポートコード：MRC-IM31170 ▷ お問い合わせ（見積依頼・ご注文・質問）